HLS Therapeutics Dividends
HLS Stock | CAD 5.00 0.03 0.60% |
As of the 4th of August 2025, Dividend Paid And Capex Coverage Ratio is likely to grow to 588.50, while Dividends Paid is likely to drop 0.00. HLS Therapeutics' past performance could be the main factor of why investors trade HLS Therapeutics stock today. Investors should clearly understand every aspect of the HLS Therapeutics dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest HLS Therapeutics' dividend schedule and payout information. HLS Therapeutics dividends can also provide a clue to the current valuation of HLS Therapeutics.
Last Reported | Projected for Next Year | ||
Dividend Yield | 0.02 | 0.02 | |
Dividend Payout Ratio | (0.08) | (0.08) | |
Dividend Paid And Capex Coverage Ratio | 560.47 | 588.50 |
HLS |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in HLS Therapeutics must own a stock before its ex-dividend date to receive its next dividend.